NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity

NEXGEL (NASDAQ:NXGL) rescheduled its fourth quarter and full-year 2025 financial results conference call to April 8, 2026 at 4:30 P.M.

Rhea-AI Summary

NEXGEL (NASDAQ:NXGL) rescheduled its fourth quarter and full-year 2025 financial results conference call to April 8, 2026 at 4:30 P.M. ET to allow more time to provide shareholders detail on its previously announced proposed transaction with Celularity.

The company filed its Form 10-K for year ended December 31, 2025 with the SEC on March 31, 2026. Call dial-in numbers and a webcast will be available for investors.

Argus Apr 1 session

-1.31% close to close Open Argus

Details

News Market Reaction – NXGL

On Apr 1, the first trading day after this news, NXGL closed 1.31% below the previous close.

Data tracked by StockTitan Argus for the Apr 1 session.

Market Context

This announcement rescheduled NEXGEL’s fourth quarter and full-year 2025 conference call to April 8,...

Analysis

This announcement rescheduled NEXGEL’s fourth quarter and full-year 2025 conference call to April 8, 2026 at 4:30 P.M. ET and highlighted that a Form 10-K for the year ended December 31, 2025 would be filed on March 31, 2026. Management also plans to give more detail on the previously announced Celularity transaction. Investors may watch upcoming filings, call commentary, and follow-on updates to assess execution and capital needs against the current low share price and trading range.

Key Figures

Conference call date: April 8, 2026 Conference call time: 4:30 P.M. ET Toll-free dial-in: 1-800-267-6316 +5 more

Conference call date

April 8, 2026

Rescheduled Q4 and FY 2025 results call

Conference call time

4:30 P.M. ET

Timing for financial results and Celularity update

Toll-free dial-in

1-800-267-6316

U.S. access number for April 8, 2026 call

International dial-in

1-203-518-9783

International access number for April 8, 2026 call

Form 10-K period end

December 31, 2025

Year-end for Annual Report on Form 10-K

10-K filing date

March 31, 2026

Company stated it will file Form 10-K on this date

Price change

-7.95%

24-hour move before the rescheduling announcement

52-week range

$0.5772–$3.09

Low and high prior to this news

Previous Conferences,earnings Reports

5 past events · Latest: Nov 03

Same Type 5 events

1. Nov 03

   Earnings call notice

   24h Move

   -4.5%

   Announced Q3 2025 results date and conference call logistics.

2. Aug 06

   Earnings call notice

   24h Move

   -7.0%

   Set Q2 2025 results date and post-close conference call details.

3. May 09

   Earnings call notice

   24h Move

   -0.6%

   Scheduled Q1 2025 financial results and investor call timing.

4. Mar 19

   Earnings call notice

   24h Move

   -1.9%

   Announced Q4 and full-year 2024 results release and call.

5. Nov 11

   Earnings call notice

   24h Move

   +8.0%

   Set Q3 2024 results date and conference call information.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

form 10-k, annual report, webcast, nasdaq, +1 more

5 terms

form 10-k regulatory

"The Company will file its Annual Report on Form 10-K for the year ended December 31, 2025"

A Form 10-K is a comprehensive report that publicly traded companies are required to file annually with regulators. It provides a detailed overview of a company's financial health, operations, and risks, similar to a detailed health report. Investors use this information to assess the company's performance and make informed decisions about buying or selling its stock.

annual report regulatory

"The Company will file its Annual Report on Form 10-K for the year ended December 31, 2025"

An annual report is a comprehensive, year-end document a publicly traded company issues that presents its financial statements, management’s discussion of results, business strategy, and key risks. Investors use it like a combined report card and roadmap to judge a company’s financial health, how it makes money, and whether its plans and risks are likely to raise or lower future value, helping inform buy, hold, or sell decisions.

webcast technical

"Webcast: Events and Presentations"

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

nasdaq financial

"NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”)"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

View in glossary

u.s. securities and exchange commission regulatory

"with the U.S. Securities and Exchange Commission today, March 31, 2026."

The U.S. Securities and Exchange Commission is a government agency responsible for overseeing the stock market and protecting investors. It sets rules to ensure that companies share truthful information and that trading is fair, helping to maintain trust in the financial system. This oversight is important because it helps prevent fraud and ensures that investors can make informed decisions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LANGHORNE, Pa., March 31, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced the rescheduling of its fourth quarter and fiscal year 2025 financial results conference call to April 8, 2026 at 4:30 P.M. ET to provide additional time for the Company to provide shareholders with greater detail regarding its previously announced proposed transaction with Celularity Inc.

The Company will file its Annual Report on Form 10-K for the year ended December 31, 2025, with the U.S. Securities and Exchange Commission today, March 31, 2026.

Fourth Quarter and Full Year 2025 Financial Results Conference Call Details:
Date: April 8, 2026
Time: 4:30 P.M. ET
Live Call: 1-800-267-6316 (U.S. Toll Free) or 1-203-518-9783 (International)
Webcast: Events and Presentations

About NEXGEL, Inc.
NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include SilverSeal^®, Hexagels^®, Turfguard^®, Kenkoderm^® and Silly George^®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

Forward-Looking Statement
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “potential,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs, such as “will,” “should,” “lends,” “would,” “may,” and “could,” are generally forward-looking in nature and not historical facts, including, without limitation, our ability to consummate the potential acquisition and the related additional investment. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance, or achievements to be materially different from any anticipated results, performance, or achievements for many reasons. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company's forward-looking statements, please see the Company's Annual Report on Form 10-K for the year ended December 31, 2024, including but not limited to the discussion under “Risk Factors” therein, which the Company filed with the SEC and which may be viewed at http://www.sec.gov/.

Investor Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
Nexgel@KCSA.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did NEXGEL (NXGL) reschedule its Q4 and FY2025 earnings call to April 8, 2026?

The company rescheduled to allow more time to provide greater detail on the proposed Celularity transaction. According to the company, the extra time is intended to give shareholders a fuller update on the previously announced transaction ahead of the results discussion.

When will NEXGEL (NXGL) present its fourth quarter and full-year 2025 results on the rescheduled call?

NEXGEL will present results on April 8, 2026 at 4:30 P.M. ET. According to the company, the call replaces the prior date and will include a live dial-in and webcast for investors.

How can investors access the NEXGEL (NXGL) April 8, 2026 conference call and webcast?

Investors can join by calling 1-800-267-6316 (U.S.) or 1-203-518-9783 (international) or via webcast. According to the company, the webcast is available under Events and Presentations on the investor site.

Did NEXGEL (NXGL) file its 2025 Annual Report (Form 10-K), and when was it filed?

Yes, NEXGEL filed its Annual Report on Form 10-K for the year ended December 31, 2025 on March 31, 2026. According to the company, the filing was completed prior to announcing the rescheduled conference call.

Will the NEXGEL (NXGL) call discuss the proposed transaction with Celularity in detail?

Yes, the company said the April 8 call will provide additional detail on the proposed transaction with Celularity. According to the company, the rescheduling was made specifically to permit a fuller shareholder update about that transaction.

What should shareholders do if they cannot join the live NEXGEL (NXGL) call on April 8, 2026?

Shareholders unable to join live can listen to the webcast replay or review the 10-K filing for financial details. According to the company, the webcast will be archived under Events and Presentations for later access.